Ruxolitinib (INCB018424) | Selleck Chemicals S1378 product information

product summary

company name :

Selleck Chemicals

product type :

chemical

product name :

Ruxolitinib (INCB018424)

catalog :

S1378

quantity :

10 g

price :

33,500.00 USD

more info or order :

Selleck Chemicals product webpage

citations: 2

Reference
Chuang C, Greenside P, Rogers Z, Brady J, Yang D, Ma R, et al. Molecular definition of a metastatic lung cancer state reveals a targetable CD109-Janus kinase-Stat axis. Nat Med. 2017;23:291-300 pubmed publisher
Bao Y, Cao X, Luo D, Sun R, Peng L, Wang L, et al. Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis. Cell Cycle. 2014;13:1958-69 pubmed publisher

product information

Catalog Number :

S1378

Product Name :

Ruxolitinib (INCB018424)

Synonyms :

INCB018424

Target :

JAK

CAS Number :

941678-49-5, 941678-50-8 (TFA), 1092939-15-5 (Maleic acid)

Formula :

C17H18N6

Quantity :

10 g

List Price :

33,500.00 USD

Description :

Ruxolitinib (INCB018424) is an orally bioavailable JAK inhibitor (IC50 values for JAK1, JAK2 and JAK3 are 3, 5 and 332 nM, respectively). Find all the information about Ruxolitinib (INCB018424) for cell signaling research.

Product Type :

Chemical

more info or order :

Selleck Chemicals product webpage